Do Guidelines Preclude Hepatitis B Patients from Receiving Treatment?

被引：6
|
作者：
Degertekin, Bulent [1 ]
Lok, Anna S. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA
来源：
HEPATOLOGY | 2009年 / 49卷 / 02期
关键词：
LAMIVUDINE;
D O I：
10.1002/hep.22722
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：700 / 701
页数：2
相关论文
共 50 条
  • [21] Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
    Voican, C. S.
    Mir, O.
    Loulergue, P.
    Dhooge, M.
    Brezault, C.
    Dreanic, J.
    Chaussade, S.
    Pol, S.
    Coriat, R.
    ANNALS OF ONCOLOGY, 2016, 27 (12) : 2172 - 2184
  • [22] Investigation of Efficacy and Safety in Chronic Hepatitis B Patients Receiving Tenofovir Alafenamide Treatment
    Kahveci, Huseyin Nadir
    Yildiz, Orhan
    Karabulut, Kaan
    Ture, Zeynep
    Unuvar, Gamze Kalin
    Aygen, Bilgehan
    JOURNAL OF CLINICAL PRACTICE AND RESEARCH, 2024, 46 (04):
  • [23] Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents
    Juan, Joshua
    Feld, Jordan J.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (04) : 395 - 403
  • [24] WHO publishes first guidelines for hepatitis B treatment
    EUROSURVEILLANCE, 2015, 20 (10):
  • [25] Current Treatment Guidelines for Chronic Hepatitis B and Their Applications
    Uribe, Lindsay A.
    O'Brien, Connor G.
    Wong, Robert J.
    Gish, Robert R.
    Tsai, Naoky
    Nguyen, Mindie H.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (09) : 773 - 783
  • [26] CHARACTERISTICS OF UNTREATED HEPATITIS B PATIENTS DESPITE TREATMENT ELIGIBILITY ACCORDING TO EXPERT GUIDELINES FOLLOWED BY THE CANADIAN HEPATITIS B NETWORK
    Ko, Hin Hin
    Cooper, Curtis
    Manko, Anna
    Ramji, Alnoor
    Doucette, Karen E.
    Fung, Scott K.
    Minuk, Gerald Y.
    Elkhashab, Magdy
    Tam, Edward V.
    Ma, Mang M.
    Brahmania, Mayur
    Bailey, Robert J.
    Wong, Philip
    Conway, Brian
    Tsoi, Keith
    Nudo, Carmine G.
    Zhu, Julie
    Osiowy, Carla
    Congly, Stephen E.
    Shaheen, Abdel-Aziz
    Coffin, Carla S.
    HEPATOLOGY, 2022, 76 : S1061 - S1062
  • [27] The WHO guidelines for chronic hepatitis B fails to detect half of the patients in need of treatment
    Aberra, H.
    Desalegn, H.
    Berhe, N.
    Medhin, G.
    Gundersen, S. G.
    Johannessen, A.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S490 - S490
  • [28] Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy
    Ikeda, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (01) : 8 - 16
  • [29] Hepatitis B reactivation in patients receiving targeted therapies
    Chang, Cheng-Shyong
    Tsai, Chien-Yu
    Yan, Sheng-Lei
    HEMATOLOGY, 2017, 22 (10) : 592 - 598
  • [30] Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir
    Xu, J. -H.
    Song, L. -W.
    Li, N.
    Wang, S.
    Zeng, Z.
    Si, C. -W.
    Li, J.
    Mao, Q.
    Zhang, D. -Z.
    Tang, H.
    Sheng, J. -F.
    Chen, X. -Y.
    Ning, Q.
    Shi, G. -F.
    Xie, Q.
    Yuan, Q.
    Yu, Y. -Y.
    Xia, N. -S.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (02) : 148 - 154
12345